Current:Home > InvestIn reaching US Open semis, Ben Shelton shows why he may be America's next men's tennis superstar -GrowthInsight
In reaching US Open semis, Ben Shelton shows why he may be America's next men's tennis superstar
View
Date:2025-04-15 23:40:56
NEW YORK — The wildest ride in tennis is a 20-year-old American from Atlanta via Gainesville, Florida, with a booming serve, a flair for showmanship and a ravenous appetite for risk.
But at the end of the day, Ben Shelton is now a US Open semifinalist — and a potential superstar. After beating fellow American and No. 10 seed Frances Tiafoe 6-2, 3-6, 7-6, 6-2 under the lights at Arthur Ashe Stadium, he will now face tennis’ ultimate test Friday against 23-time Grand Slam champion Novak Djokovic.
“It doesn’t get much better than that,” Shelton said.
Though Tiafoe came in as the better-known player and fan favorite thanks to his semifinal run here last year, the 6-foot-4 Shelton began drawing gasps right away for his explosive athleticism and willingness to push the limits of a radar gun that was clocking many of his serves in the 130 and even 140 mph range.
But more importantly, he dictated play from the first ball and made Tiafoe deeply uncomfortable with the depth and power of his shots. In some ways, Shelton’s most difficult opponent Tuesday was his temptation to play too big in certain moments, losing the second set and nearly the third when his discipline fell apart.
In fact, it appeared Shelton had blown the crucial tiebreaker when he worked hard to get to 6-5, within one point of the set, only to double fault on consecutive points and hand Tiafoe the advantage.
But Shelton, playing true to his go-for-broke identity, smoked a massive forehand — his best of the entire match — that nicked the right sideline and left Tiafoe stunned with no attempt to retrieve it.
“Sometimes you've got to shut off the brain, close your eyes and just swing,” said Shelton, who closed out the tiebreaker with two solid points from there. “Maybe there was a little bit of that down set point but it ended up working out. Some may say clutch, but I don't know about all that.”
If the tiebreaker was more luck than clutch, what followed certainly showed that he can be a good closer. He immediately broke serve to open the fourth set and raced away without even a hint of trouble, ripping away any hope of a Tiafoe comeback.
Shelton, who won the NCAA men’s singles championship at Florida in 2022, turned pro a year ago and immediately made a splash by making the Australian Open quarterfinals in January.
But that run, aided by a soft draw, in some ways made his life on tour more difficult. With a big target on his back and trying to navigate new tournaments and unfamiliar surfaces in Europe, Shelton did not win back-to-back matches at the ATP level until he arrived in New York.
But in this tournament, Shelton has shown why so many experts consider him the best American prospect to come along in many years — and why he still has significant upside that hasn't been realized.
But for as raw as many of his skills are, Shelton has clearly made some big improvements in this rookie year. The most notable has been his return of serve, which had been holding him back throughout the year but is coming along right on time.
It was the shot that made the biggest difference against Tiafoe, as Shelton was consistently able to produce quality returns and get into rallies where he was the better player. He ultimately broke Tiafoe seven times, winning 50% of the points on second serve and 37% on Tiafoe’s first serve.
This match will be a bitter disappointment for Tiafoe, who vowed after his five-set loss to Carlos Alcaraz in the semifinals last year that he would one day win this tournament. And it was setting up to be a special night for him in the first-ever matchup between two African-American men this deep in the US Open.
“I think it's a big night for people of color looking up to Ben and I knowing they can be in these positions," Tiafoe said in his pre-match interview on ESPN.
But at the end of the night, Shelton’s relentless energy and high-voltage game looked like the stuff that could eventually make him the first American man to win a Grand Slam since Andy Roddick in 2003.
veryGood! (64763)
Related
- Taylor Swift Eras Archive site launches on singer's 35th birthday. What is it?
- Coasts Should Plan for 6.5 Feet Sea Level Rise by 2100 as Precaution, Experts Say
- Can Solyndra’s Breakthrough Solar Technology Outlive the Company’s Demise?
- Journalists: Apply Now for ICN’s Southeast Environmental Reporting Workshop
- Friday the 13th luck? 13 past Mega Millions jackpot wins in December. See top 10 lottery prizes
- Trump’s Move to Suspend Enforcement of Environmental Laws is a Lifeline to the Oil Industry
- This Week in Clean Economy: New Report Puts Solyndra Media Coverage in Spotlight
- Changing our clocks is a health hazard. Just ask a sleep doctor
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- High inflation and housing costs force Americans to delay needed health care
Ranking
- Bill Belichick's salary at North Carolina: School releases football coach's contract details
- How Miley Cyrus Feels About Being “Harshly Judged” as Child in the Spotlight
- The first wiring map of an insect's brain hints at incredible complexity
- EU Utilities Vow End to Coal After 2020, as Trump Promises Revival
- Former Danish minister for Greenland discusses Trump's push to acquire island
- All Eyes on Minn. Wind Developer as It Bets on New ‘Flow Battery’ Storage
- Dakota Pipeline Builder Rebuffed by Feds in Bid to Restart Work on Troubled Ohio Gas Project
- A roadblock to life-saving addiction treatment is gone. Now what?
Recommendation
All That You Wanted to Know About She’s All That
21 Essentials For When You're On A Boat: Deck Shoes, Bikinis, Mineral Sunscreen & More
This Week in Clean Economy: U.S. Electric Carmakers Get the Solyndra Treatment
What worries medical charities about trying to help Syria's earthquake survivors
Travis Hunter, the 2
The 4 kidnapped Americans are part of a large wave of U.S. medical tourism in Mexico
Sickle cell patient's success with gene editing raises hopes and questions
Infection toll for recalled eyedrops climbs to 81, including 4 deaths, CDC says